Matches in Nanopublications for { ?s ?p "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982428.RAS_rVzqWUcnLTU2q6uvpcbBBJ9lp_N3W-TE0K6cGTlG0130_provenance.
- NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_assertion description "[The BCR-ABL T315I kinase domain mutation is insensitive to dasatinib therapy for Philadelphia-positive acute lymphoid leukemia (Ph + ALL) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP982427.RAFqKwil9QfTNdy5U28ECLO9qSVLUajTt6OriXNamtOpM130_provenance.